Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
ANGPTL3 encodes a member of a family of secreted proteins that function in angiogenesis. De plus, nous expédions ANGPTL3 Kits (81) et ANGPTL3 Protéines (38) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 185 products:
Human Polyclonal ANGPTL3 Primary Antibody pour ELISA, WB - ABIN1169294
Broxmeyer, Srour, Cooper, Wallace, Hangoc, Youn: Angiopoietin-like-2 and -3 act through their coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors. dans Blood cells, molecules & diseases 2012
Human Polyclonal ANGPTL3 Primary Antibody pour ELISA - ABIN449832
Jin, Wang, Millar, Quertermous, Rothblat, Glick, Rader: Hepatic proprotein convertases modulate HDL metabolism. dans Cell metabolism 2007
Knockdown of Angptl3 decreases liver size in developing zebrafish.
Subjects who carried ANGPTL3 sequence variants rs12563308 and rs199772471 had abnormally high total cholesterol and LDL-cholesterol concentrations.
circulating ANGPTL3 and ANGPTL 4 (Montrer ANGPTL4 Anticorps) expression was significantly elevated in hepatocellular carcinoma cases compared to chronic hepatitis patients and controls
ANGPTL8 has a functional LPL (Montrer LCP1 Anticorps) inhibitory motif, but only inhibits LPL (Montrer LCP1 Anticorps) and increases plasma TG levels in mice in the presence of ANGPTL3
Our findings demonstrate that complete ANGPTL3 deficiency associates with highly reduced postprandial lipemia probably due to faster catabolism of intestinally derived lipoproteins, larger expansion of the postprandial FFA pool, and decreased influx of dietary-derived fatty acids into the liver. These results add information on mechanisms underlying hypolipidemia in familial combined hypolipidemia (FHBL2).
participants with heterozygous loss-of-function variants in ANGPTL3 had significantly lower serum levels of triglycerides, HDL (Montrer HSD11B1 Anticorps) cholesterol, and LDL cholesterol than participants without these variants.
ANGPTL3 deficiency is associated with protection from coronary artery disease.
our data shows that ANGPTL3, 4 and 8 are increased in obesity and type 2 diabetes (T2D). ANGPTL8 associates with ANGPTL3 in the non-diabetic subjects while it associated more with ANGPTL4 (Montrer ANGPTL4 Anticorps) in the obese and T2D subjects.
ANGPTL3 is specifically correlated with HDL (Montrer HSD11B1 Anticorps)-c, apoA-I (Montrer APOA1 Anticorps), SAA (Montrer SAA1 Anticorps) and HDL (Montrer HSD11B1 Anticorps) function in female non-diabetic participants. The decrease of ANGPTL3 level in female T2DM patients might contribute to its weak association to HDL (Montrer HSD11B1 Anticorps) components and function.
The ANGPTL3 gene lies within DOCK7 (Montrer DOCK7 Anticorps), although the variant is within non-coding regions outside of ANGPTL3, within DOCK7 (Montrer DOCK7 Anticorps), suggesting complex long-range regulatory effects on gene expression in coronary artery disease.
ANGPTL3 levels were associated with fasting insulin (Montrer INS Anticorps) and the homeostasis model assessment of insulin (Montrer INS Anticorps) resistance in Korean children.
ANGPTL8 has a functional LPL (Montrer LPL Anticorps) inhibitory motif, but only inhibits LPL (Montrer LPL Anticorps) and increases plasma TG levels in mice in the presence of ANGPTL3
The data suggests that ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL (Montrer LPL Anticorps) inhibition in mastitis mice.
Using in vitro ketosis model by glucose starvation, studied inhibition of ketosis by momilactone B. Found momilactone B could regulate the angiopoietin-like-3 (ANGPTL3)-lipoprotein lipase (LPL (Montrer LPL Anticorps))pathway, and suppressed the expression of HMGCS2 (Montrer HMGCS2 Anticorps) through the increased expression of STAT5b (Montrer STAT5B Anticorps).
This model suggests a general mechanism by which TAG trafficking is coordinated by lipasin, Angptl3 and Angptl4 (Montrer ANGPTL4 Anticorps) at different nutritional statuses.
Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion
The deletion of ANGPTL3 tremendously attenuates proteinuria and protects podocytes from injury in a mouse model of adriamycin-induced nephropathy.
ANGPTL3 has a role in regulating white adipose tissue energy homeostasis but not in liver
Data indicate that expression of Angptl3 in hematopoietic stem cell (HSC (Montrer FUT1 Anticorps)) through lentiviral transduction promoted HSC (Montrer FUT1 Anticorps) expansion.
Angptl3 could induce actin filament rearrangement, mainly in lamellipodia formation, and that this process was mediated by integrin alpha(V)beta-mediated FAK and PI3K phosphorylation and Rac1 activation.
Furin (Montrer FURIN Anticorps) has a role as the primary in vivo convertase of ANGPTL3 and endothelial lipase (Montrer LIPG Anticorps) in hepatocytes
First report of molecular cloning and characterization of ANGPTL3 in pigs, which will be helpful for a better understanding of the role of ANGPTLs in lipid metabolism.
This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metablism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2.
, WITHDRAWN: zgc:111943
, angiopoietin-related protein 3-like
, angiopoietin 5
, angiopoietin-related protein 3
, angiopoietin-like protein 3